Product Information
SAXAGLIPTIN HCL 2.5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.1813 per EA under NDC 00378470593. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
2.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378470593
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SAXAGLIPTIN HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205980On Market Since
8/4/2023
Pharmacological Classes
Price Statistics
The NADAC for SAXAGLIPTIN HCL 2.5 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 80.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1813 per EA |
|---|---|
| All-time high | $6.0820 (May 15, 2024) |
| All-time low | $1.1813 (Jun 17, 2026) |
| 52-week high | $5.2363 |
| 52-week low | $1.1813 |
| Median price | $4.2377 |
| Average price | $3.8296 |
| Largest weekly change | -19.9% (Oct 22, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SAXAGLIPTIN HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN HCL 2.5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $1.1813 per EA (NDC 00378470593), effective Jun 24, 2026.
How has the price of SAXAGLIPTIN HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SAXAGLIPTIN HCL 2.5 MG TABLET has declined 80.6%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN HCL 2.5 MG TABLET?
Since Apr 17, 2024, the NADAC for SAXAGLIPTIN HCL 2.5 MG TABLET has ranged from a low of $1.1813 (Jun 17, 2026) to a high of $6.0820 (May 15, 2024), with a median of $4.2377 per EA.
Are there cheaper alternatives to SAXAGLIPTIN HCL 2.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SAXAGLIPTIN HCL 2.5 MG TABLET, but none are currently priced below it.
Who manufactures SAXAGLIPTIN HCL 2.5 MG TABLET?
SAXAGLIPTIN HCL 2.5 MG TABLET (NDC 00378470593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification